Report Id: SNS/HC/2522 | July 2022 | Region: Global | 127 Pages
Report Scope & Overview:
The Low-Pressure Liquid Chromatography Market Size was valued at USD 6.77 billion in 2022, and is expected to reach USD 12.07 billion by 2030, and grow at a CAGR of 7.5% over the forecast period 2023-2030.
Low-pressure liquid chromatography (LPLC) is a technique that uses low pressure to force the mobile phase through the column. To investigate the properties of biomolecules including proteins, peptides, and monoclonal antibodies, low-pressure liquid chromatography is used. One of the best biomolecule separation methods for separating recombinant-tagged proteins is low-pressure liquid chromatography. Additionally, the method is employed to clean small and complex samples, remove pollutants from test samples, and purify active pharmaceutical components. The low-pressure liquid chromatography systems are also simple to use and built to deliver the desired outcomes. Additionally, researchers are developing novel low-pressure liquid chromatography techniques for the extraction and purification of paclitaxel from plant tissue culture fluid.
Protein-based vaccinations are becoming more common.
Increasing spending on R&D projects
More cutting-edge technology is being included into clinical laboratories.
Worries about the production of bubbles during pressure pulsation
protein-based medications to address inherited conditions
IMPACT OF COVID-19
The COVID-19 pandemic slowed down product development and production in a variety of industries. During the pandemic outbreak, the pharmaceutical industry and R&D institutions experienced a decline in market demand. During the first quarter of COVID-19, low-pressure liquid chromatography demand decreased, which affected market participants. However, the market demand has been boosted by the rising demand for vaccines and supportive medications. The market for low-pressure liquid chromatography products was driven by the increasing urgency of coronavirus vaccinations and life-saving medications. In addition, the market for low-pressure liquid chromatography is being driven by rising R&D efforts to provide diagnostic and therapeutic goods. Additionally, a growing number of pharmaceutical companies and the government invested in installing machinery that specializes in protein and peptide separation, opening doors for those working in the sector.
In therapeutic research, low-pressure liquid chromatography has produced ground-breaking breakthroughs. One of the most important and effective methods for SARS-CoV-2 medication development is the protein extraction technology. Additionally, in order to speed up medication development, commercial and public authorities worked together, opening doors for the producers of low-pressure liquid chromatography. A pandemic epidemic increased the requirement for R&D efforts; therefore, market participants produced a lot of low-pressure liquid chromatography to suit those needs. To stop the fatal virus from spreading, the production and transportation of the equipment were carried out under strict controls. Furthermore, due to substantial investment in drug development operations, the pandemic epidemic caused a financial imbalance among the healthcare research organisations.
Instruments are a particular class of tool used for precise operations. Chromatographic separations are carried out with the aid of these devices. Pumps, detectors, columns, and flow cells are some examples of the instruments.
Consumables: This is a product utilised in the liquid chromatography techniques. clean-up cartridges, Filters, and solvent extraction dispersant are examples of low-pressure liquid chromatography consumables.
Services: It is an action and doesn't involve moving real things. The services offered for low-pressure liquid chromatography products include installation, instruction, maintenance, and repairs.
By End User
Pharmaceutical companies are a specific kind of business that develop, research, and manufacture both generic and name-brand drugs. Low-pressure liquid chromatography equipment is used by pharmaceutical companies to develop new generic and specialised medications.
Companies that use live creatures, such as bacteria or enzymes, to produce medications are known as "biotechnology companies." Low-pressure liquid chromatography equipment is being used by biotechnology companies to separate complicated chemicals from microorganisms.
Research Laboratories: This category of workplace specializes in the regulated conduct of scientific investigations, tests, and measurements. Clinical trials on molecular components are carried out in research laboratories using low-pressure liquid chromatography equipment.
Academic Institution: This category of educational facility focuses on training and research activities. Practitioners can obtain academic degrees from these universities as well. Institutionally, academic institutions conduct educational learning and research using low-pressure liquid chromatography equipment.
Some of the major key players are as follow: Danaher Corporation, Biolinx Labsystems, GALAK Chromatography Technology Co., Ltd., Nilsan Nishotech Systems Pvt. Ltd, LEWA GmbH, Novasep.
By End User
Due to increased investment in adeno-associated viral therapy, increased use of precise and effective liquid chromatography, and increased funding for the creation of new gene-therapy-based products, North America accounted for the largest share of the global market for low-pressure liquid chromatography. Additionally, the region's growing elderly population and rising demand for diagnostic tests are propelling the demand for products utilizing low-pressure liquid chromatography. According to estimates, these elements will propel the market for low-pressure liquid chromatography in North America.
The development of various diseases, the rise in the elderly population, increased investments in research facilities, and favourable government regulations all contribute to the growth of the Asia-Pacific low-pressure liquid chromatography market. These elements are anticipated to fuel demand for low-pressure liquid chromatography over the projected timeframe. Increasing investment to support current clinical studies and drug research is also expected to speed up the sale of low-pressure liquid chromatography throughout the region.
Rest of Europe
Rest of Asia-Pacific
The Middle East & Africa
Rest of Middle East & Africa
Rest of Latin America
|Market Size in 2022||US$ 6.77 Billion|
|Market Size by 2030||US$ 12.07 Billion|
|CAGR||CAGR of 7.5% From 2023 to 2030|
|Report Scope & Coverage||Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook|
|Key Segments||• By Component (Instruments, Consumables, Services)
• By End User (Pharmaceutical Companies, Biotechnology Companies, Research Laboratories, Academic Institution)
|Regional Analysis/Coverage||North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
|Company Profiles||Danaher Corporation, Biolinx Labsystems, GALAK Chromatography Technology Co., Ltd., Nilsan Nishotech Systems Pvt. Ltd, LEWA GmbH, Novasep.|
|Key Drivers||• Protein-based vaccinations are becoming more common.
• Increasing spending on R&D projects
|RESTRAINTS||• Worries about the production of bubbles during pressure pulsation|
Frequently Asked Questions (FAQ) :
Ans. Low-Pressure Liquid Chromatography Market Size was expected to reach USD 10.5 billion by 2028
Ans. Instruments, Consumables, and Services are sub segments of by application of Low-Pressure Liquid Chromatography market.
Ans. Low-pressure liquid chromatography (LPLC) is a technique that uses low pressure to force the mobile phase through the column. To investigate the properties of biomolecules including proteins, peptides, and monoclonal antibodies, low-pressure liquid chromatography is used.
Ans. Danaher Corporation, Biolinx Labsystems, GALAK Chromatography Technology Co., Ltd., and Nilsan Nishotech Systems Pvt. Ltd are key players of Low-Pressure Liquid Chromatography Market.
Ans. Yes, this report covers qualitative and quantitative analysis.
Table of Contents
1.1 Market Definition
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.2 Impact on major economies
184.108.40.206 United Kingdom
220.127.116.11 South Korea
18.104.22.168 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Low-Pressure Liquid Chromatography Market Segmentation, By Component
9. Low-Pressure Liquid Chromatography Market Segmentation, By End User
9.1 Pharmaceutical Companies
9.2 Biotechnology Companies
9.3 Research Laboratories
9.4 Academic Institution
10. Regional Analysis
10.2 North America
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4.2 South Korea
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.3 South Africa
10.6 Latin America
10.6.3 Rest of Latin America
11.1 Danaher Corporation
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Biolinx Labsystems
11.3 GALAK Chromatography Technology Co., Ltd.
11.4 Nilsan Nishotech Systems Pvt. Ltd
11.5 LEWA GmbH
12.1 Competitive Benchmark
12.2 Market Share analysis
12.3 Recent Developments
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of a good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach a stage wherein we can provide our clients best and most accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research as the name suggests is a research process wherein, we collect data through readily available information. In this process, we use various paid and unpaid databases to which our team has access and gather data through the same. This includes examining listed companies’ annual reports, Journals, SEC filling, etc. Apart from this, our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various universities as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content-specific facts that can be sued to solve specific problems. Since the collected data is fresh and first-hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply sides of the industry to make sure we land an accurate judgment and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses, and observation of on-field participants. The below-mentioned chart should give a better understanding of part 1 of the primary interview.
Part 2: In this part of the primary research the data collected via secondary research and part 1 of the primary research is validated with the interviews with individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence center, our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real-time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but is not limited to getting rid of the many typos, duplication of numbers, or missing any important information. The people involved in this process include technical content writers, research heads, and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.